scPharmaceuticals Inc.

scPharmaceuticals Inc.

SCPH
scPharmaceuticals Inc.US flagNASDAQ Global Select
5.67
USD
- -
- -
302.20MMarket Cap

Income Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
14
36
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
14
36
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
4
11
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
4
11
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
10
25
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
11
18
23
30
33
30
26
36
65
90
+ Selling, General & Admin
3
6
9
14
8
12
10
21
53
78
+ Research & Development
8
12
14
16
25
18
16
16
12
12
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-11
-18
-23
-30
-33
-30
-26
-36
-55
-65
- Non-Operating (Income) Loss
- -
6
- -
- -
- -
2
2
1
-1
20
+ Interest Expense, Net
- -
7
- -
- -
- -
2
3
2
3
4
+ Interest Expense
- -
7
1
1
2
3
3
3
8
8
- Interest Income
- -
- -
- -
2
2
- -
- -
1
5
3
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
-1
-4
16
Pretax Income
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
EBIT
-11
-18
-23
-30
-33
-30
-26
-36
-55
-65
EBITDA
-11
-18
-23
-29
-33
-30
-25
-36
-55
-65
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-407.36
-178.23
EBITA
-11
-18
-23
-30
-33
-30
-26
-36
-55
-65
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
71.96
68.73
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-407.53
-178.29
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-403.22
-234.36
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
11
11
3
19
19
25
27
28
39
45
Basic EPS, GAAP
-0.94
-2.18
-8.04
-1.59
-1.77
-1.31
-1.02
-1.3
-1.42
-1.91
Basic EPS from Cont Ops
-0.94
-2.18
-8.04
-1.59
-1.77
-1.31
-1.02
-1.3
-1.42
-1.91
Diluted Weighted Avg Shares
11
11
3
19
19
25
27
28
39
45
Diluted EPS, GAAP
-0.94
-2.18
-8.04
-1.59
-1.77
-1.31
-1.02
-1.3
-1.42
-1.91
Diluted EPS from Cont Ops
-0.94
-2.18
-8.04
-1.59
-1.77
-1.31
-1.02
-1.3
-1.42
-1.91

Balance Sheet (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Total Current Assets
2
40
120
92
76
108
78
123
93
106
+ Cash, Cash Equivalents & STI
2
39
118
89
73
105
75
118
76
76
+ Cash & Cash Equivalents
2
39
118
89
73
72
74
71
47
76
+ ST Investments
- -
- -
- -
- -
- -
33
1
47
29
- -
+ Accounts & Notes Receiv
- -
- -
1
- -
- -
- -
- -
- -
4
12
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
4
12
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
1
9
14
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
1
4
5
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
4
7
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
2
3
3
3
4
4
5
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
2
2
2
1
1
1
2
2
+ Property, Plant & Equip, Net
- -
- -
2
2
1
1
- -
1
1
1
+ Property, Plant & Equip
- -
- -
2
2
1
1
1
1
2
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
2
40
122
94
77
109
79
124
94
108
+ Payables & Accruals
2
4
4
3
4
4
3
4
9
9
+ Accounts Payable
1
2
2
1
1
2
1
2
4
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
2
2
2
3
3
2
5
5
+ ST Debt
- -
- -
1
3
- -
3
10
1
- -
- -
+ ST Borrowings
- -
- -
- -
3
- -
2
10
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Other ST Liabilities
- -
- -
1
1
1
2
1
3
4
5
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
1
1
1
2
1
3
4
5
Total Current Liabilities
2
4
5
7
5
9
15
7
13
15
+ LT Debt
- -
- -
11
8
20
17
7
37
40
52
+ LT Borrowings
- -
- -
9
7
19
17
7
37
39
51
+ LT Finance Leases
- -
- -
2
1
1
- -
- -
- -
1
1
+ Other LT Liabilities
18
73
- -
- -
1
- -
- -
8
4
27
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
27
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
18
73
- -
- -
1
- -
- -
8
4
- -
Total Noncurrent Liabilities
18
73
11
8
21
18
8
44
44
79
Total Liabilities
20
77
16
15
26
27
23
52
57
94
+ Preferred Equity and Hybrid Capital
- -
73
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
6
173
175
181
244
246
299
319
380
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
6
173
175
181
244
246
299
319
380
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-19
-43
-67
-96
-129
-162
-190
-227
-281
-366
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-18
-37
106
79
51
82
56
72
37
13
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-18
-37
106
79
51
82
56
72
37
13
Total Liabilities & Equity
2
40
122
94
77
109
79
124
94
108
Shares Outstanding
18
18
19
19
19
27
27
34
36
50
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
2
2
1
1
- -
1
1
1
Net Debt
-2
-39
-109
-80
-54
-53
-57
-34
-8
-24
Net Debt to Equity
8.62
105.96
-102.72
-101.39
-104.56
-63.96
-101.13
-47.31
-21.5
-182.47
Tangible Common Equity Ratio
-988.08
-277.02
86.85
83.99
66.46
75.35
71.45
58.32
39.39
12.39
Current Ratio
0.91
10.64
23.01
13.77
14.44
11.57
5.27
16.63
7.08
7.12
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
454.31
359.16

Cash Flow Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
+ Net Income
-11
-24
-24
-29
-33
-32
-28
-37
-55
-85
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
7
1
3
2
3
3
2
2
28
+ Stock-Based Compensation
- -
1
1
2
1
2
2
3
5
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Other Non-Cash Adj
- -
7
- -
- -
- -
1
1
-1
-4
22
+ Chg in Non-Cash Work Cap
1
1
- -
-2
- -
1
-3
- -
-6
-13
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
-4
-7
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
-1
-8
-5
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-1
-1
- -
- -
-1
- -
-1
+ Inc (Dec) in Accts Payable
1
2
1
-1
1
1
-2
2
6
1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
-15
-23
-29
-30
-28
-27
-35
-59
-71
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
93
- -
4
60
- -
48
14
54
+ Increase in Capital Stock
- -
- -
93
- -
4
61
- -
48
14
54
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
-33
32
-46
20
29
+ Dec in LT Investment
- -
- -
- -
- -
- -
39
41
22
71
29
+ Inc in LT Investment
- -
- -
- -
- -
- -
-72
-9
-68
-51
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-33
32
-46
20
29
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
13
9
- -
10
- -
-2
30
- -
-3
+ Cash From Debt
- -
13
9
- -
10
- -
- -
47
- -
47
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
-2
-18
- -
-50
+ Other Financing Activities
8
41
- -
- -
- -
- -
- -
- -
1
20
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
8
53
102
- -
14
60
-3
77
15
70
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-2
38
79
-29
-17
-1
2
-3
-24
29
EBITDA
-11
-18
-23
-29
-33
-30
-25
-36
-55
-65
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-407.36
-178.23
Free Cash Flow
-10
-15
-23
-29
-30
-28
-27
-35
-59
-71
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
70
-87
-29
-21
-28
-30
-5
-59
-74
Free Cash Flow per Basic Share
-0.86
-1.38
-7.72
-1.55
-1.64
-1.13
-0.99
-1.22
-1.54
-1.58
Price/Free Cash Flow
- -
- -
-1.59
-2.42
-3.46
-4.69
-5.06
-5.88
-4.08
-2.23
Cash Flow to Net Income
0.92
0.63
0.95
0.98
0.92
0.86
0.97
0.94
1.08
0.83
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -